HK1203388A1 - Polymer-based dialysate - Google Patents

Polymer-based dialysate

Info

Publication number
HK1203388A1
HK1203388A1 HK15104009.4A HK15104009A HK1203388A1 HK 1203388 A1 HK1203388 A1 HK 1203388A1 HK 15104009 A HK15104009 A HK 15104009A HK 1203388 A1 HK1203388 A1 HK 1203388A1
Authority
HK
Hong Kong
Prior art keywords
polymer
based dialysate
dialysate
Prior art date
Application number
HK15104009.4A
Other languages
English (en)
Chinese (zh)
Inventor
Jayachandran Kizhakkedathu
Caigan Du
Roza Gerald Da
Asher Mendelson
Original Assignee
Univ British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ British Columbia filed Critical Univ British Columbia
Publication of HK1203388A1 publication Critical patent/HK1203388A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/04—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers only
    • C08G65/22—Cyclic ethers having at least one atom other than carbon and hydrogen outside the ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/0014—Special media to be introduced, removed or treated removed from the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0496—Urine
    • A61M2202/0498—Urea
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2340/00—Filter material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Obesity (AREA)
  • Polymers & Plastics (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Polyethers (AREA)
  • Materials Applied To Surfaces To Minimize Adherence Of Mist Or Water (AREA)
HK15104009.4A 2012-04-24 2015-04-24 Polymer-based dialysate HK1203388A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261637716P 2012-04-24 2012-04-24
PCT/CA2013/000382 WO2013159188A1 (fr) 2012-04-24 2013-04-18 Dialysat à base de polymère

Publications (1)

Publication Number Publication Date
HK1203388A1 true HK1203388A1 (en) 2015-10-30

Family

ID=49482059

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15104009.4A HK1203388A1 (en) 2012-04-24 2015-04-24 Polymer-based dialysate

Country Status (15)

Country Link
US (1) US9919004B2 (fr)
EP (1) EP2841078A4 (fr)
JP (1) JP6240665B2 (fr)
KR (1) KR20150013161A (fr)
CN (1) CN104640550A (fr)
AU (1) AU2013252433B2 (fr)
BR (1) BR112014026616A2 (fr)
CA (1) CA2871277A1 (fr)
CL (1) CL2014002891A1 (fr)
CO (1) CO7190239A2 (fr)
HK (1) HK1203388A1 (fr)
MX (1) MX2014012942A (fr)
MY (1) MY170307A (fr)
PE (1) PE20150288A1 (fr)
WO (1) WO2013159188A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9346029B2 (en) 2005-06-06 2016-05-24 The University Of British Columbia Polymer-based serum albumin substitute
CN106432747B (zh) 2010-03-01 2019-11-05 不列颠哥伦比亚大学 衍生的超支化聚丙三醇
CN105960165B (zh) * 2013-11-21 2021-03-23 李沙丹 基于聚合物的移植用保存溶液
US10202507B2 (en) 2014-05-29 2019-02-12 The University Of British Columbia Antithrombotic compounds, methods and uses thereof
EP3120842A1 (fr) * 2015-07-20 2017-01-25 Opterion Health AG Fluide thérapeutique péritonéal
JP6721880B2 (ja) * 2016-03-25 2020-07-15 国立大学法人神戸大学 正浸透膜を使用して膜分離する方法
US10874790B2 (en) 2016-08-10 2020-12-29 Medtronic, Inc. Peritoneal dialysis intracycle osmotic agent adjustment
GR1009311B (el) * 2017-01-26 2018-06-19 Βερμα Ντραγκς - Verma Drugs Abee Οξινο κιτρικο διαλυμα αιμοκαθαρσης με l-καρνιτινη
EP3381484A1 (fr) * 2017-03-31 2018-10-03 Opterion Health AG Composition à base de glucide pour dialyse
WO2019210414A1 (fr) * 2018-05-02 2019-11-07 Arc Medical Devices Inc. Composés et complexes à base de fucane
US11806457B2 (en) * 2018-11-16 2023-11-07 Mozarc Medical Us Llc Peritoneal dialysis adequacy meaurements
US11806456B2 (en) 2018-12-10 2023-11-07 Mozarc Medical Us Llc Precision peritoneal dialysis therapy based on dialysis adequacy measurements
US11965763B2 (en) 2021-11-12 2024-04-23 Mozarc Medical Us Llc Determining fluid flow across rotary pump

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3461210A (en) * 1967-07-20 1969-08-12 Unimed Inc Reduction of intraocular pressure
JPS61247466A (ja) * 1985-04-25 1986-11-04 テルモ株式会社 腹膜透析用透析液
EP1223985B1 (fr) * 1999-10-15 2005-11-30 Dow Global Technologies Inc. Solution de dialyse contenant un agent osmotique polyglycol
US20030202958A1 (en) * 1999-10-15 2003-10-30 Strickland Alan D. Dialysis solution including polyglycol osmotic agent
US6949335B2 (en) 1999-11-30 2005-09-27 21St Century Medicine, Inc. Polyglycerol and lactose compositions for the protection of living systems from states of reduced metabolism
US9346029B2 (en) * 2005-06-06 2016-05-24 The University Of British Columbia Polymer-based serum albumin substitute
DE102006036326A1 (de) * 2006-08-03 2008-02-07 Charité - Universitätsmedizin Berlin Dendritische Polyglycerolsulfate und -sulfonate und deren Verwendung bei entzündlichen Erkrankungen
WO2008074154A1 (fr) 2006-12-18 2008-06-26 The University Of British Columbia Polymères à groupes terminaux zwitterioniques
WO2009055935A1 (fr) 2007-11-02 2009-05-07 The University Of British Columbia Polyglycérol hyperramifié pour améliorer la fonction cardiaque
CN106432747B (zh) 2010-03-01 2019-11-05 不列颠哥伦比亚大学 衍生的超支化聚丙三醇
WO2012162789A1 (fr) 2011-06-01 2012-12-06 University Of British Columbia Polymères pour inverser une anticoagulation à base d'héparine

Also Published As

Publication number Publication date
PE20150288A1 (es) 2015-02-22
CN104640550A (zh) 2015-05-20
US20150141512A1 (en) 2015-05-21
JP6240665B2 (ja) 2017-11-29
AU2013252433A1 (en) 2014-11-20
MY170307A (en) 2019-07-17
CL2014002891A1 (es) 2015-05-04
WO2013159188A1 (fr) 2013-10-31
JP2015515481A (ja) 2015-05-28
CO7190239A2 (es) 2015-02-19
MX2014012942A (es) 2015-02-10
US9919004B2 (en) 2018-03-20
EP2841078A1 (fr) 2015-03-04
KR20150013161A (ko) 2015-02-04
AU2013252433B2 (en) 2017-12-14
EP2841078A4 (fr) 2015-11-04
CA2871277A1 (fr) 2013-10-31
BR112014026616A2 (pt) 2017-06-27

Similar Documents

Publication Publication Date Title
HK1203388A1 (en) Polymer-based dialysate
DK3327112T3 (en) Agse-deficient stamme
GB201201578D0 (en) Polymer
GB201214565D0 (en) Membrane
EP2754580A4 (fr) Camion-benne
DK2830816T3 (en) Hidtil ukendt coatingkoncept
EP2935220A4 (fr) Péri-carbinols
GB2513034B (en) Polymer
GB201411209D0 (en) Polymer
EP2920142A4 (fr) Méthanofullerrènes
EP2878318A4 (fr) Appareil de dialyse
EP2812698A4 (fr) Fret à résolution temporelle et accepteur double
EP2906215A4 (fr) Combinaisons
EP2920157A4 (fr) Di-macrocycles
EP2873363A4 (fr) Diopsimètre
GB2506739B (en) Dialysis device
EP2834250A4 (fr) Silicates de lithium
GB201209515D0 (en) Bougie
GB201216124D0 (en) Dialysis solution
GB201219665D0 (en) Membranes
GB201219629D0 (en) Membranes
GB201216146D0 (en) Membranes
GB201312314D0 (en) Polymer
GB201217917D0 (en) Solutions
GB201215818D0 (en) Anti-wrapping unit